Answers are grounded in this paper and cite their sources.
Dopaminergic neuroimaging, particularly dopamine transporter SPECT, is a potentially useful imaging biomarker of the severity of Parkinson disease.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: